Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity.

Oh, Jaeseong; Yi, Sojeong; Gu, Namyi; Shin, Dongseong; Yu, Kyung-Sang; Yoon, Seo Hyun; Cho, Joo-Youn; Jang, In-Jin

Oh, Jaeseong; Yi, Sojeong; Gu, Namyi; Shin, Dongseong; Yu, Kyung-Sang; Yoon, Seo Hyun; Cho, Joo-Youn; Jang, In-Jin.

Afiliação

Oh J; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, 03080, Korea.
Yi S; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 10903, USA.
Gu N; Department of Clinical Pharmacology and Therapeutics, Clinical Trial Center, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang 10326, Korea.
Shin D; Clinical Trials Center, Gachon University Gil Medical Center, Incheon 21565, Korea.
Yu KS; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, 03080, Korea.
Yoon SH; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, 03080, Korea.
Cho JY; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, 03080, Korea.
Jang IJ; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, 03080, Korea.

Genomics Inform ; 16(3): 52-58, 2018 Sep.

Article em En | MEDLINE | ID: mdl-30309203

Palavras-chave

clinical trial; metabolomics; new drug development; pharmacogenomics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Genomics Inform Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google